.jpeg?#)
AstraZeneca, Novartis execute ‘US for US’ strategy as pharma tariffs near
With the industry on tenterhooks on what the pharma-specific tariffs may look like, AstraZeneca and Novartis said Tuesday that their local production capacity will be key in sidestepping these levies. “Our goal, as I mentioned ...
With the industry on tenterhooks on what the pharma-specific tariffs may look like, AstraZeneca and Novartis said Tuesday that their local production capacity will be key in sidestepping these levies.
“Our goal, as I mentioned ...
